- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06547671
Efficacy of a Sensory Comfort Room in Agitation Control
Evaluation of the Effectiveness of a Comfort-sensory Room in the Control of Agitation in a Functional Mental Health Rehabilitation Area
In the initial approach of the study, it was considered that the comfort room would be used by all patients with GCT treated in the Functional Rehabilitation Area 1 (ARF 1) of the Álava Psychiatric Hospital. However, with the onset of the covid-19 pandemic, the service itself decided to separate the patients into two units, in order to reduce positive contacts. Consequently, the use of the comfort room will only be available for one of the two units, which will be considered as the intervention group, while the other unit will be considered as the control group. It is also important to note that the patients in the intervention group unit have a more severe mental state than those in the control group. The control group are older and more psychopathologically stable patients. So already from the initial moment of the study they are two populations with different characteristics.
Main Objective:
To determine the effectiveness of the use of a sensory comfort room in the functional rehabilitation area 1 of the HPA. It would be considered effective if mechanical restraints decrease by 5% in the intervention group with respect to the previous year.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alava
-
Vitoria-gasteiz, Alava, Spain
- Araba University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- All patients admitted to functional rehabilitation area 1 presenting with questionable, mild or moderate Agitation (score less than or equal to 20 on the PEC scale) or at the patient's request.
- To have freely accepted to participate in the intervention and to have signed the informed consent. An information sheet will also be given to the patient and an information sheet to the tutor (APPENDIXES 1 and 2). Experts in easy reading are consulted to adapt this document.
Exclusion criteria:
- Severe and extremely severe agitation (score greater than or equal to 21 on the PEC scale). Immediate previous physical aggression.
- Declination of the signature of informed consent.
- Any participant who does not comply with the rules of use of the room will be excluded from the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Comfort room
Use of the sensory comfort room located in the unit itself, decorated in soft and relaxing tones with motifs inspired by nature. It has relaxation sofas, rocking chair, aromatherapy, chromotherapy, projector, music of the user's choice, weighted blanket mats, balls of various sizes......... to teach people admitted to the area alternatives to cope and control anxiety and prevent the escalation of agitation, as well as to guide them in strategies to help them relax. In addition, as usual clinical practice, both before and after the intervention, verbal de-escalation techniques will be used, for which the professionals in the area have been trained with a verbal de-escalation course specifically for working in the area. The intervention is not unique but in several uses of the sensory comfort room in each patient. The intervention will last approximately 30 minutes and can be used several times during the day. Furthermore, patients received the same follow up than the control group. |
Use of the sensory comfort room located in the unit itself, decorated in soft and relaxing tones with motifs inspired by nature.
It has relaxation sofas, rocking chair, aromatherapy, chromotherapy, projector, music of the user's choice, weighted blanket mats, balls of various sizes......... to teach people admitted to the area alternatives to cope and control anxiety and prevent the escalation of agitation, as well as to guide them in strategies to help them relax.
|
|
No Intervention: Usual clinical practice
Follow up of patients, in the same way as in routine clinical practice.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of mechanical restraints
Time Frame: Up to 24 months
|
Mechanical restraint is understood as the extreme therapeutic intervention, through the application of immobilizing restrictive devices to limit a patient's freedom and, in turn, allows us to ensure their own safety and/or that of other
|
Up to 24 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in the agitation level
Time Frame: Through study completion, an average of 2 years
|
Agitation Score in Positive and Negative Symptoms Scale, Excitement Component (PEC) It is a scale with five items: Tension; Uncooperativeness; Hostility; Poor impulse control; and Excitement. Each of these items is rated with the following scores: 1. Absent. 2. Minimal. 3. Mild. 4. Moderate. Moderately severe. 6. Severe. 7. Extreme. A higher score on the PEC scale indicates greater agitation. The classification of the level of agitation is as follows: Questionable (5-10 points), mild (11-15 points) Moderate (16-20 points) Moderately severe (20-25 points) Severe (26-30 points or Item "impulse control" > 4) Extremely severe (30-35 points). Whether or not the score on the PEC scale is lower before using the room and afterwards will be evaluated (15). It is considered that there is a decrease in the PEC scale if it is lower by one point. Before room use and afterwards. |
Through study completion, an average of 2 years
|
|
Number of isolations
Time Frame: Up to 24 months
|
Defined as the supervised confinement of a patient in a locked room alone for a period of time to protect the patient, or staff, from serious harm
|
Up to 24 months
|
|
Number of patients who need Rescue medication
Time Frame: Up to 24 months
|
Rescue medication to overcome the crisis
|
Up to 24 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patients satisfaction questionnaire with confort room
Time Frame: Through study completion, an average of 2 years
|
Satisfaction and Proposals for room improvement, completed after each use
|
Through study completion, an average of 2 years
|
|
Professionals satisfaction questionaire with confort room
Time Frame: Through study completion, an average of 2 years
|
About their experience with the employment of room, completed after each use
|
Through study completion, an average of 2 years
|
|
Age
Time Frame: At baseline
|
Numerical variable
|
At baseline
|
|
Sex
Time Frame: At baseline
|
Male, famale
|
At baseline
|
|
Cognitive level with mini-mental scale.
Time Frame: At baseline
|
This is the most widely used brief cognitive test in Spain.
It is mainly used to detect cognitive disorders associated with neurodegenerative diseases such as Alzheimer's disease.
There are 2 versions of 30 and 35 points.
The test has 5 items (orientation, fixation, concentration and calculation, memory, language and construction).
Impairment is considered to be present when the score is less than 23 points
|
At baseline
|
|
Age of mental disease evolution
Time Frame: At baseline
|
Numerical variable
|
At baseline
|
|
Diagnosis
Time Frame: At baseline
|
According to the International Classification of Diseases
|
At baseline
|
Collaborators and Investigators
Investigators
- Principal Investigator: MARIA OLÁRIZU OLALDE, Basque Health Service
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AGITCONF2024
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mental Disorders, Severe
-
Alejando Vargas RubioActive, not recruitingSevere Mental Disorder | Severe Mental IllnessSpain
-
University of KwaZuluColumbia University; Medical Research Council, South Africa; Universiteit AntwerpenRecruitingMental Disorders, SevereSouth Africa
-
University Hospital, ToursNot yet recruiting
-
Alejando Vargas RubioCompletedSevere Mental Disorder | Severe Mental IllnessSpain
-
IRCCS Centro San Giovanni di Dio FatebenefratelliRecruitingSevere Mental Disorder | Severe Mental IllnessItaly
-
University of ManchesterEuropean Research CouncilRecruitingMental Disorders, SevereUnited Kingdom
-
Fundació Institut de Recerca de l'Hospital de la...CompletedMental Disorders, SevereSpain
-
University of North Carolina, Chapel HillU.S. Department of JusticeCompletedMental Disorders, SevereUnited States
-
Liga Romana pentru Sanatate MintalaPsychiatric Hospital for Chronic Patients Siret, Suceava, RomaniaUnknown
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and Development; Onze...RecruitingMental Disorders, SevereNetherlands
Clinical Trials on Employment of a confort room to help in anxiety and agitation moments.
-
Zonguldak Bulent Ecevit UniversityCompletedPostoperative Delirium | Preoperative AnxietyTurkey
-
T.C. ORDU ÜNİVERSİTESİCompletedCOVID-19 | Metabolic Syndrome | Emotional EatingTurkey
-
Ataturk UniversityCompletedAnesthesia, Local | Cesarean Section Complications | HypotensionTurkey
-
Memorial Sloan Kettering Cancer CenterCompletedNon-Hodgkin's Lymphoma | CNS Lymphoma | CNS Brain CancerUnited States
-
Duke UniversityTerminatedLaparoscopic Colorectal ResectionUnited States